help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EID, A. A.
Right arrow Articles by SHALE, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EID, A. A.
Right arrow Articles by SHALE, D. J.

Am. J. Respir. Crit. Care Med., Volume 164, Number 8, October 2001, 1414-1418

Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease

ABDULLAH A. EID, ALINA A. IONESCU, LISETTE S. NIXON, VANESSA LEWIS-JENKINS, STEPHANIE B. MATTHEWS, TIMOTHY L. GRIFFITHS, and DENNIS J. SHALE

Section of Respiratory Medicine, University of Wales College of Medicine; and Department of Nutrition and Dietetics and Department of Medical Biochemistry, Cardiff and Vale NHS Trust, Llandough Hospital, Penarth, South Glamorgan, UK

Weight loss in chronic obstructive airways disease (COPD) is associated with an increased energy cost of breathing. To determine an association between body composition and the inflammatory response we studied 80 clinically stable patients. Body composition was determined anthropometrically and skeletal muscle mass was determined as the creatinine-height index (CHI). Forty patients had their nitrogen balance determined. Circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor alpha  (TNF-alpha ), and their soluble receptors were determined for 68 patients. Body mass index (BMI) was normal (> 20 kg/m2) in 55 patients, of whom 17 (31%) had a low CHI (< 80% predicted). A reduced CHI was associated with increased circulating levels of IL-6 (p = 0.001), TNF-alpha (p = 0.032) and their soluble receptors IL-6sr (p = 0.002), TNF-alpha sr1 (p = 0.03), and TNF-alpha sr2 (p = 0.001). Patients with a normal BMI and low CHI had inflammatory mediator levels similar to patients with a low BMI and CHI; both were significantly greater than in those with a normal BMI and CHI. Nitrogen balance was similar between normal and low CHI groups, although nitrogen excretion was significantly increased in the low CHI group. Skeletal muscle loss in COPD is probably multifactorial in origin, but our data suggest a link with systemic inflammation, even when weight loss is inapparent.




This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
J. A. Falk, O. A. Minai, and Z. Mosenifar
Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 506 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
K. M. Kunisaki, K. L. Rice, E. N. Janoff, T. S. Rector, and D. E. Niewoehner
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 55 - 64.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
P. D. Wagner
Possible mechanisms underlying the development of cachexia in COPD
Eur. Respir. J., March 1, 2008; 31(3): 492 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J., February 1, 2008; 31(2): 416 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
M. Poulain, M. Doucet, V. Drapeau, G. Fournier, A. Tremblay, P. Poirier, and F. Maltais
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Chronic Respiratory Disease, February 1, 2008; 5(1): 35 - 41.
[Abstract] [PDF]

Home page
 CirculationHome page
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation, December 18, 2007; 116(25): 2992 - 3005.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. A. Smith, J. S. Moylan, J. D. Smith, W. Li, and M. B. Reid
IFN-{gamma} does not mimic the catabolic effects of TNF-{alpha}
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1947 - C1952.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi
Skeletal muscle adaptations to testosterone and resistance training in men with COPD
J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
S. I. Rennard
Inflammation in COPD: a link to systemic comorbidities
Eur. Respir. Rev., September 1, 2007; 16(105): 91 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Doucet, A. P. Russell, B. Leger, R. Debigare, D. R. Joanisse, M.-A. Caron, P. LeBlanc, and F. Maltais
Muscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 261 - 269.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Tomoda, M. Yoshikawa, T. Itoh, S. Tamaki, A. Fukuoka, K. Komeda, and H. Kimura
Elevated Circulating Plasma Adiponectin in Underweight Patients With COPD
Chest, July 1, 2007; 132(1): 135 - 140.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1259 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J. Vestbo
Systemic inflammation and progression of COPD
Thorax, June 1, 2007; 62(6): 469 - 470.
[Full Text] [PDF]

Home page
 ThoraxHome page
M. C Steiner
Sarcopaenia in chronic obstructive pulmonary disease
Thorax, February 1, 2007; 62(2): 101 - 103.
[Full Text] [PDF]

Home page
 ThoraxHome page
C. E Bolton, R. Broekhuizen, A. A Ionescu, L. S Nixon, E. F M Wouters, D. J Shale, and A. M W J Schols
Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD
Thorax, February 1, 2007; 62(2): 109 - 114.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
V. M. Pinto-Plata, G. Livnat, M. Girish, H. Cabral, P. Masdin, P. Linacre, R. Dew, L. Kenney, and B. R. Celli
Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD
Chest, January 1, 2007; 131(1): 37 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. P. Hersh, D. T. Miller, D. J. Kwiatkowski, and E. K. Silverman
Genetic determinants of C-reactive protein in COPD
Eur. Respir. J., December 1, 2006; 28(6): 1156 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, J. L. J. van der Velden, E. F. M. Wouters, and Y. M. W. Janssen-Heininger
Muscle Wasting and Impaired Muscle Regeneration in a Murine Model of Chronic Pulmonary Inflammation
Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 689 - 696.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. C. Roos, A. J. Ostor, H. Okamoto, M. A. Dentener, E. F.M. Wouters, D.L. Scott, and G.H. Kingsley
Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis
N. Engl. J. Med., November 9, 2006; 355(19): 2046 - 2048.
[Full Text] [PDF]

Home page
 ChestHome page
P. Joppa, D. Petrasova, B. Stancak, and R. Tkacova
Systemic Inflammation in Patients With COPD and Pulmonary Hypertension.
Chest, August 1, 2006; 130(2): 326 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters
Approaches to Improving Health Status in Chronic Obstructive Pulmonary Disease: One or Several?
Proceedings of the ATS, May 1, 2006; 3(3): 262 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Similowski, A. Agusti, W. MacNee, and B. Schonhofer
The potential impact of anaemia of chronic disease in COPD
Eur. Respir. J., February 1, 2006; 27(2): 390 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Vestbo, E. Prescott, T. Almdal, M. Dahl, B. G. Nordestgaard, T. Andersen, T. I. A. Sorensen, and P. Lange
Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample: Findings from the Copenhagen City Heart Study
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 79 - 83.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S Yende, G W Waterer, E A Tolley, A B Newman, D C Bauer, D R Taaffe, R Jensen, R Crapo, S Rubin, M Nevitt, et al.
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects
Thorax, January 1, 2006; 61(1): 10 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
R. Broekhuizen, R. F Grimble, W M. Howell, D. J Shale, E. C Creutzberg, E. F Wouters, and A. M Schols
Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1{beta} -511 single nucleotide polymorphism
Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1059 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1105 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Couillard and C. Prefaut
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Eur. Respir. J., October 1, 2005; 26(4): 703 - 719.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. C. Donaldson, T. A. R. Seemungal, I. S. Patel, A. Bhowmik, T. M. A. Wilkinson, J. R. Hurst, P. K. MacCallum, and J. A. Wedzicha
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Chest, October 1, 2005; 128(4): 1995 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Montes de Oca, S. H. Torres, J. De Sanctis, A. Mata, N. Hernandez, and C. Talamo
Skeletal muscle inflammation and nitric oxide in patients with COPD
Eur. Respir. J., September 1, 2005; 26(3): 390 - 397.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
W D-C Man, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, and J Moxham
Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease
Thorax, September 1, 2005; 60(9): 718 - 722.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. D. Sin, L. Wu, and S. F. P. Man
The Relationship Between Reduced Lung Function and Cardiovascular Mortality: A Population-Based Study and a Systematic Review of the Literature
Chest, June 1, 2005; 127(6): 1952 - 1959.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
W. MacNee
Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 50 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. F. van Eeden, A. Yeung, K. Quinlam, and J. C. Hogg
Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 61 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. F. P. Man and D. D. Sin
Effects of Corticosteroids on Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 78 - 82.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. I. Rennard
Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Proceedings of the ATS, April 1, 2005; 2(1): 94 - 100.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. C. Donaldson, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, and J. A. Wedzicha
Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 446 - 452.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. Q. Gan, S.F. P. Man, and D. D. Sin
The Interactions Between Cigarette Smoking and Reduced Lung Function on Systemic Inflammation
Chest, February 1, 2005; 127(2): 558 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Sethi
Musculoskeletal Effects of Chronic Obstructive Pulmonary Disease: Prevalent, Linked, but Ignored
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1267 - 1268.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. E. Bolton, A. A. Ionescu, K. M. Shiels, R. J. Pettit, P. H. Edwards, M. D. Stone, L. S. Nixon, W. D. Evans, T. L. Griffiths, and D. J. Shale
Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1286 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Vassilakopoulos, C. Roussos, and S. Zakynthinos
The immune response to resistive breathing
Eur. Respir. J., December 1, 2004; 24(6): 1033 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Itoh, N. Nagaya, M. Yoshikawa, A. Fukuoka, H. Takenaka, Y. Shimizu, Y. Haruta, H. Oya, M. Yamagishi, H. Hosoda, et al.
Elevated Plasma Ghrelin Level in Underweight Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 879 - 882.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. S. Rana, M. A. Mittleman, J. Sheikh, F. B. Hu, J. E. Manson, G. A. Colditz, F. E. Speizer, R. G. Barr, and C. A. Camargo Jr
Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women
Diabetes Care, October 1, 2004; 27(10): 2478 - 2484.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Vassilakopoulos, M. Divangahi, G. Rallis, O. Kishta, B. Petrof, A. Comtois, and S. N. A. Hussain
Differential Cytokine Gene Expression in the Diaphragm in Response to Strenuous Resistive Breathing
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 154 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Coronell, M. Orozco-Levi, R. Mendez, A. Ramirez-Sarmiento, J.B. Galdiz, and J. Gea
Relevance of assessing quadriceps endurance in patients with COPD
Eur. Respir. J., July 1, 2004; 24(1): 129 - 136.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
W Q Gan, S F P Man, A Senthilselvan, and D D Sin
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
Thorax, July 1, 2004; 59(7): 574 - 580.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Gluck and G. Colice
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Chest, May 1, 2004; 125(5): 1859 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. Godoy, A.O. Campana, R.R.C. Geraldo, C.R. Padovani, and S.A.R Paiva
Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients
Eur. Respir. J., December 1, 2003; 22(6): 920 - 925.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. A. Ionescu, W. D. Evans, R. J. Pettit, L. S. Nixon, M. D. Stone, and D. J. Shale
Hidden Depletion of Fat-Free Mass and Bone Mineral Density in Adults With Cystic Fibrosis
Chest, December 1, 2003; 124(6): 2220 - 2228.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.W. Boots, G.R.M.M. Haenen, and A. Bast
Oxidant metabolism in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 14S - 27s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.A. Ionescu and E. Schoon
Osteoporosis in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 64S - 75s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.M.W.J. Schols
Nutritional and metabolic modulation in chronic obstructive pulmonary disease management
Eur. Respir. J., November 2, 2003; 22(46_suppl): 81S - 86s.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Panzner, J.-J. Lafitte, A. Tsicopoulos, Q. Hamid, and M. K. Tulic
Marked Up-regulation of T Lymphocytes and Expression of Interleukin-9 in Bronchial Biopsies From Patients With Chronic Bronchitis With Obstruction
Chest, November 1, 2003; 124(5): 1909 - 1915.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
I Sermet-Gaudelus, J C Souberbielle, I Azhar, J C Ruiz, P Magnine, V Colomb, C Le Bihan, D Folio, and G Lenoir
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients
Arch. Dis. Child., November 1, 2003; 88(11): 956 - 961.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C E Bolton, A A Ionescu, W D Evans, R J Pettit, and D J Shale
Altered tissue distribution in adults with cystic fibrosis
Thorax, October 1, 2003; 58(10): 885 - 889.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M I Polkey
Peripheral muscle weakness in COPD: where does it come from?
Thorax, September 1, 2003; 58(9): 741 - 742.
[Full Text] [PDF]

Home page
 ThoraxHome page
M A Spruit, R Gosselink, T Troosters, A Kasran, G Gayan-Ramirez, P Bogaerts, R Bouillon, and M Decramer
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I
Thorax, September 1, 2003; 58(9): 752 - 756.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H.R. Gosker, B. Kubat, G. Schaart, G.J. van der Vusse, E.F.M. Wouters, and A.M.W.J. Schols
Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
Eur. Respir. J., August 1, 2003; 22(2): 280 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.A. Rabinovich, M. Figueras, E. Ardite, N. Carbo, T. Troosters, X. Filella, J.A. Barbera, J.C. Fernandez-Checa, J.M. Argiles, and J. Roca
Increased tumour necrosis factor-{alpha} plasma levels during moderate-intensity exercise in COPD patients
Eur. Respir. J., May 1, 2003; 21(5): 789 - 794.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. D. Sin and S.F. P. Man
Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Circulation, March 25, 2003; 107(11): 1514 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets
Systemic effects of chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2003; 21(2): 347 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Vassilakopoulos, P. Katsaounou, M.-H. Karatza, A. Kollintza, S. Zakynthinos, and C. Roussos
Strenuous Resistive Breathing Induces Plasma Cytokines: Role of Antioxidants and Monocytes
Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1572 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. H. Vernooy, M. Kucukaycan, J. A. Jacobs, N. H. Chavannes, W. A. Buurman, M. A. Dentener, and E. F. Wouters
Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease: Soluble Tumor Necrosis Factor Receptors Are Increased in Sputum
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1218 - 1224.